A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
F cells measure the presence of fetal hemoglobin, a heritable quantitative trait in adults that accounts for substantial phenotypic diversity of sickle cell disease and beta thalassemia. We applied a genome-wide association mapping strategy to individuals with contrasting extreme trait values and mapped a new F cell quantitative trait locus to BCL11A, which encodes a zinc-finger protein, on chromosome 2p15. The 2p15 BCL11A quantitative trait locus accounts for 15.1% of the trait variance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BCL11A is a repressor of HbF gene expression.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [14]
Citations
Cites
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Population Structure and Eigenanalysis
Patterson, N., Price, A. L., & Reich, D. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020190 · Cited by 5,280
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
A General Test of Association for Quantitative Traits in Nuclear Families
Abecasis, G. R., Cardon, L. R., & Cookson, W. O. C. (2000) · The American Journal of Human Genetics · doi:10.1086/302698 · Cited by 1,126
Disorders of hemoglobin genetics, pathophysiology, and clinical management
Steinberg, M. H. (2001) · Cited by 438
Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management
Somervaille, T. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109401119 · Cited by 432
Bcl11a is essential for normal lymphoid development
Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G. (2003) · Nature Immunology · doi:10.1038/ni925 · Cited by 351
Thein, S. L., Menzel, S., Peng, X., Best, S., Jiang, J., Close, J., Silver, N., Gerovasilli, A., Ping, C., Yamaguchi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611393104 · Cited by 314
Self-citationGenetic influences on F cells and other hematologic variables: a twin heritability study
Garner, C., Tatu, T., Reittie, J. E., Littlewood, T., Darley, J., Cervino, S., Farrall, M., Kelly, P., Spector, T. D., & Thein, S. L. (2000) · Blood · doi:10.1182/blood.v95.1.342 · Cited by 274
Self-citationRegulation of human fetal hemoglobin: new players, new complexities
Bank, A. (2006) · Blood · doi:10.1182/blood-2005-05-2113 · Cited by 209
Cited by
Items 101–200 of 534
Wahlberg, K., Jiang, J., Rooks, H., Jawaid, K., Matsuda, F., Yamaguchi, M., Lathrop, M., Thein, S. L., & Best, S. (2009) · Blood · doi:10.1182/blood-2009-03-210146 · Cited by 89
Self-citationZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression
Lan, X., Ren, R., Feng, R., Ly, L. C., Lan, Y., Zhang, Z., Aboreden, N. G., Qin, K., Horton, J. R., Grevet, J. D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.006 · Cited by 97
Determinants of severity in sickle cell disease
Rees, D. C., Brousse, V. A. M., & Brewin, J. N. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100983 · Cited by 108
Bhatnagar, P., Purvis, S., Barron-Casella, E., DeBaun, M. R., Casella, J. F., Arking, D. E., & Keefer, J. R. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.12 · Cited by 90
Thalassemia 2016: Modern medicine battles an ancient disease
Rund, D. G. (2015) · American Journal of Hematology · doi:10.1002/ajh.24231 · Cited by 89
Therapeutic adenine base editing of human hematopoietic stem cells
Liao, J., Chen, S., Hsiao, S., Jiang, Y., Yang, Y., Zhang, Y., Wang, X., Lai, Y., Bauer, D. E., & Wu, Y. (2023) · Nature Communications · doi:10.1038/s41467-022-35508-7 · Cited by 94
Molecular Basis and Genetic Modifiers of Thalassemia
Tesio, N., & Bauer, D. E. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.001 · Cited by 103
Gene therapy of hemoglobinopathies: progress and future challenges
Ikawa, Y., Miccio, A., Magrin, E., Kwiatkowski, J. L., Rivella, S., & Cavazzana, M. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz172 · Cited by 86
“The B cell CLL/lymphoma 11A (BCL11A) protein is a major modulator of HbF expression (36,37), and genetic variation in the erythroid enhancer of BCL11A affects its expression and, consequently, HbF levels (38).”
BackgroundTisdale, J. F., Thein, S. L., & Eaton, W. A. (2020) · Science · doi:10.1126/science.aba3827 · Cited by 95
Self-citationMicroarray Technology and Applications in the Arena of Genome-Wide Association
Grant, S. F. A., & Hakonarson, H. H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105395 · Cited by 91
Sequence three million genomes across Africa
Wonkam, A. (2021) · Nature · doi:10.1038/d41586-021-00313-7 · Cited by 93
Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
Mansilla-Soto, J., Riviere, I., Boulad, F., & Sadelain, M. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.037 · Cited by 83
Creary, L. E., Ulug, P., Menzel, S., McKenzie, C. A., Hanchard, N. A., Taylor, V., Farrall, M., Forrester, T. E., & Thein, S. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004218 · Cited by 80
Self-citationGenetic association studies in β-hemoglobinopathies
Thein, S. L. (2013) · Hematology · doi:10.1182/asheducation-2013.1.354 · Cited by 79
Self-citationBadens, C., Joly, P., Agouti, I., Thuret, I., Gonnet, K., Fattoum, S., Francina, A., Simeoni, M.-C., Loundou, A., & Pissard, S. (2011) · Haematologica · doi:10.3324/haematol.2011.046748 · Cited by 77
Genetic modifiers of -thalassemia and clinical severity as assessed by age at first transfusion
Danjou, F., Anni, F., Perseu, L., Satta, S., Dessì, C., Lai, M. E., Fortina, P. M., Devoto, M., & Galanello, R. (2012) · Haematologica · doi:10.3324/haematol.2011.053504 · Cited by 88
Huang, P., Peslak, S. A., Lan, X., Khandros, E., Yano, J. A., Sharma, M., Keller, C. A., Giardine, B. M., Qin, K., Abdulmalik, O. Y., et al. (2020) · Blood · doi:10.1182/blood.2020005301 · Cited by 81
Danjou, F., Zoledziewska, M., Sidore, C., Steri, M., Busonero, F., Maschio, A., Mulas, A., Perseu, L., Barella, S., Porcu, E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3307 · Cited by 73
Self-citationRole of the transcription factor Bcl11b in development and lymphomagenesis
Kominami, R. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.72 · Cited by 86
Martyn, G. E., Wienert, B., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2019) · Blood · doi:10.1182/blood-2018-07-863951 · Cited by 85
Satta, S., Perseu, L., Moi, P., Asunis, I., Cabriolu, A., Maccioni, L., Demartis, F. R., Manunza, L., Cao, A., & Galanello, R. (2011) · Haematologica · doi:10.3324/haematol.2010.037333 · Cited by 82
High-Throughput Genetic Mapping of Mutants via Quantitative Single Nucleotide Polymorphism Typing
Liu, S., Chen, H. D., Makarevitch, I., Shirmer, R., Emrich, S., Dietrich, C. R., Barbazuk, W. B., Springer, N. M., & Schnable, P. S. (2009) · Genetics · doi:10.1534/genetics.109.107557 · Cited by 86
Brendel, C., Negre, O., Rothe, M., Guda, S., Parsons, G., Harris, C., McGuinness, M., Abriss, D., Tsytsykova, A., Klatt, D., et al. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.03.015 · Cited by 72
Funnell, A. P. W., Prontera, P., Ottaviani, V., Piccione, M., Giambona, A., Maggio, A., Ciaffoni, F., Stehling-Sun, S., Marra, M., Masiello, F., et al. (2015) · Blood · doi:10.1182/blood-2015-04-638528 · Cited by 70
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Demirci, S., Leonard, A., Haro-Mora, J. J., Uchida, N., & Tisdale, J. F. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2018_331 · Cited by 50
Trakarnsanga, K., Wilson, M. C., Lau, W. W. Y., Singleton, B. K., Parsons, S. F., Sakuntanaga, P., Kurita, R., Nakamura, Y., Anstee, D. J., & Frayne, J. (2014) · Haematologica · doi:10.3324/haematol.2014.110155 · Cited by 76
Three fingers on the switch: Krüppel-like factor 1 regulation of γ-globin to β-globin gene switching
Tallack, M. R., & Perkins, A. C. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835f59ba · Cited by 80
Transcriptional silencing of fetal hemoglobin by BCL11A
Sankaran, V. G., Xu, J., & Orkin, S. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05574.x · Cited by 75
Thalassemia: An Overview of 50 Years of Clinical Research
Sankaran, V. G., & Nathan, D. G. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.009 · Cited by 80
Regulation of the fetal hemoglobin silencing factor BCL11A
Basak, A., & Sankaran, V. G. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13024 · Cited by 70
Genome-wide association studies and the genetic dissection of complex traits
Sebastiani, P., Timofeev, N., Dworkis, D. A., Perls, T. T., & Steinberg, M. H. (2009) · American Journal of Hematology · doi:10.1002/ajh.21440 · Cited by 67
“This first successful example of a GWAS was soon followed by several other applications to a variety of common diseases including prostate and breast cancers [22–27], Crohn’s disease [28–30], coronary artery disease and diabetes [6,31,32], fetal hemoglobin expression [33], and other traits [34].”
Lopera-Maya, E. A., van der Graaf, A., Lanting, P., van der Geest, M., Study, L. C., Fu, J., Swertz, M. A., Franke, L., Wijmenga, C., Deelen, P., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00613 · Cited by 72
QTL mapping of sake brewing characteristics of yeast
Katou, T., 浪瀬, 政., Kitagaki, H., Akao, T., & Shimoi, H. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2008.12.014 · Cited by 67
BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity
Demirci, S., Zeng, J., Wu, Y., Uchida, N., Shen, A. H., Pellin, D., Gamer, J., Yapundich, M., Drysdale, C., Bonanno, J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140189 · Cited by 66
2021 update on clinical trials in β‐thalassemia
Musallam, K. M., Bou‐Fakhredin, R., Cappellini, M. D., & Taher, A. T. (2021) · American Journal of Hematology · doi:10.1002/ajh.26316 · Cited by 74
KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells
Norton, L. J., Funnell, A. P. W., Burdach, J., Wienert, B., Kurita, R., Nakamura, Y., Philipsen, S., Pearson, R. C. M., Quinlan, K. G. R., & Crossley, M. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002303 · Cited by 65
Fetal Globin Gene Repressors as Drug Targets for Molecular Therapies To Treat the β-Globinopathies
Suzuki, M., Yamamoto, M. P., & Engel, J. D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00714-14 · Cited by 72
Jawaid, K., Wahlberg, K., Thein, S. L., & Best, S. (2010) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2010.05.006 · Cited by 64
Self-citationNguyen, T. K. T., Joly, P., Bardel, C., Moulsma, M., Bonello‐Palot, N., & Francina, A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.04.002 · Cited by 75
Erythro-megakaryocytic transcription factors associated with hereditary anemia
Crispino, J. D., & Weiss, M. J. (2014) · Blood · doi:10.1182/blood-2014-01-453167 · Cited by 69
BCL11A represses HBG transcription in K562 cells
Chen, Z., Luo, H., Steinberg, M. H., & Chui, D. H. K. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.12.003 · Cited by 66
Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies
Testa, U. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0637-y · Cited by 67
The Search for Genetic Modifiers of Disease Severity in the -Hemoglobinopathies
Lettre, G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015032 · Cited by 71
Customizing the genome as therapy for the β-hemoglobinopathies.
Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61
Progress in Genome-Wide Association Studies of Human Height
Hirschhorn, J. N., & Lettre, G. (2009) · Hormone Research in Paediatrics · doi:10.1159/000192430 · Cited by 71
Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease
Thein, S. L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_2 · Cited by 70
Self-citationGenetic complexity in sickle cell disease
Higgs, D. R., & Wood, W. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806633105 · Cited by 60
Pule, G. D., Mowla, S., Novitzky, N., & Wonkam, A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0092-7 · Cited by 62
Sripichai, O., Kiefer, C. M., Bhanu, N. V., Tanno, T., Noh, S.-J., Goh, S.-H., Russell, J. E., Rognerud, C. L., Ou, C.-N., Oneal, P. A., et al. (2009) · Blood · doi:10.1182/blood-2009-05-219386 · Cited by 59
Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression
Cheng, L., Li, Y., Qi, Q., Xu, P., Feng, R., Palmer, L. E., Chen, J., Wu, R., Yee, T., Zhang, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00861-8 · Cited by 60
HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription
Huang, P., Peslak, S. A., Ren, R., Khandros, E., Qin, K., Keller, C. A., Giardine, B. M., Bell, H. W., Lan, X., Sharma, M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01152-6 · Cited by 63
A genetic score for the prediction of beta-thalassemia severity
Danjou, F., Francavilla, M., Anni, F., Satta, S., Demartis, F. R., Perseu, L., Manca, M., Sollaino, M. C., Manunza, L., Mereu, E., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.113886 · Cited by 59
Hemoglobin S Polymerization and Red Cell Membrane Changes
Kuypers, F. A. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.12.002 · Cited by 64
CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease
Demirci, S., Leonard, A. K., Essawi, K., & Tisdale, J. F. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.09.010 · Cited by 61
Bjurström, C. F., Mojadidi, M., Phillips, J., Kuo, C., Lai, S., Lill, G. R., Cooper, A., Kaufman, M., Urbinati, F., Wang, X., et al. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.52 · Cited by 55
Fetal Hemoglobin Induction by Epigenetic Drugs
Lavelle, D., Engel, J. D., & Saunthararajah, Y. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.008 · Cited by 53
Adenovirus vectors in hematopoietic stem cell genome editing
Li, C., & Lieber, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13668 · Cited by 58
Chen, J., Zhu, W., Liu, J., Wang, G., Chen, X., Tan, Y., Xu, W., Qu, L.-W., Li, J., Yang, H.-J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00811-0 · Cited by 64
Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice
Esteghamat, F., Gillemans, N., Bilic, I., van den Akker, E., Cantù, I., van Gent, T., Klingmüller, U., van Lom, K., von Lindern, M., Grosveld, F., et al. (2013) · Blood · doi:10.1182/blood-2012-06-434530 · Cited by 51
The Molecular Basis of β Thalassemia, δβ Thalassemia, and Hereditary Persistence of Fetal Hemoglobin
Thein, S. L., & Wood, W. G. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.023 · Cited by 67
Self-citationMIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease
Li, Y., Zhu, X., Ward, C. M., Starlard‐Davenport, A., Takezaki, M., Berry, A., Ward, A., Wilder, C., Neunert, C. E., Kutlar, A., et al. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.11.002 · Cited by 56
Chi, K. R. (2009) · Nature · doi:10.1038/461712a · Cited by 52
Genetic modifiers of fetal haemoglobin in sickle cell disease
Menzel, S., & Thein, S. L. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0370-8 · Cited by 50
Self-citationTakase, S., Hiroyama, T., Shirai, F., Maemoto, Y., Nakata, A., Arata, M., Matsuoka, S., Sonoda, T., Niwa, H., Sato, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35404-0 · Cited by 56
Strict in vivo specificity of the Bcl11a erythroid enhancer
Smith, E. C., Luc, S., Croney, D. M., Woodworth, M. B., Greig, L. C., Fujiwara, Y., Nguyen, M., Sher, F., Macklis, J. D., Bauer, D. E., et al. (2016) · Blood · doi:10.1182/blood-2016-08-736249 · Cited by 48
Antoniani, C., Romano, O., & Miccio, A. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0192 · Cited by 57
Cardoso, G. L., Diniz, I. G., da Silva, A. N. L. M., Cunha, D. A., da Silva, J. S., Uchôa, C. T. C., dos Santos, S. E. B., Trindade, S. M. S., Cardoso, M. D. S. D. O., & Guerreiro, J. F. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.07.006 · Cited by 52
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis
Kirkham, J. K., Estepp, J. H., Weiss, M. J., & Rashkin, S. R. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.37484 · Cited by 54
Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches
Sripichai, O., & Fucharoen, S. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1255142 · Cited by 54
Role of the GATA-1/FOG-1/NuRD Pathway in the Expression of Human β-Like Globin Genes
Miccio, A., & Blobel, G. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00001-10 · Cited by 46
Switching from fetal to adult hemoglobin
Wang, X., & Thein, S. L. (2018) · Nature Genetics · doi:10.1038/s41588-018-0094-z · Cited by 55
Self-citationThe genetics of human hematopoiesis and its disruption in disease
Bao, E. L., Cheng, A. N., & Sankaran, V. G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910316 · Cited by 42
Fetal globin expression is regulated by Friend of Prmt1
van Dijk, T. B., Gillemans, N., Pourfarzad, F., van Lom, K., Lindern, M. V., Grosveld, F. G., & Philipsen, S. (2010) · Blood · doi:10.1182/blood-2010-03-274399 · Cited by 51
HbE/β-Thalassemia: Basis of Marked Clinical Diversity
Olivieri, N. F., Pakbaz, Z., & Vichinsky, E. P. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.008 · Cited by 53
Hemoglobin genetics: recent contributions of GWAS and gene editing
Smith, E. C., & Orkin, S. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw170 · Cited by 45
Enhancer dysfunction in leukemia
Bhagwat, A. S., Lu, B., & Vakoc, C. R. (2018) · Blood · doi:10.1182/blood-2017-11-737379 · Cited by 49
So, C.-C., Song, Y.-Q., Tsang, S. T. Y., Tang, L.-F., Chan, A. Y. Y., Ma, E. S., & Chan, L.-C. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060335 · Cited by 45
Transcriptional Mechanisms Underlying Hemoglobin Synthesis
Katsumura, K. R., DeVilbiss, A., Pope, N. J., Johnson, K. D., & Bresnick, E. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015412 · Cited by 50
Recent Advances in β-Thalassemias
Cao, A., Moi, P., & Galanello, R. (2011) · Pediatric Reports · doi:10.4081/pr.2011.e17 · Cited by 53
Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease
Green, N., & Barral, S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22754 · Cited by 50
Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells
Qin, K., Huang, P., Feng, R., Keller, C. A., Peslak, S. A., Khandros, E., Saari, M. S., Lan, X., Mayuranathan, T., Doerfler, P. A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01076-1 · Cited by 46
BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia
Sebastiani, P., Farrell, J. J., Alsultan, A., Wang, S., Edward, H. L., Shappell, H., Bae, H., Milton, J. N., Baldwin, C. T., Al-Rubaish, A. M., et al. (2015) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2015.01.001 · Cited by 41
Galarneau, G., Coady, S., Garrett, M. E., Jeffries, N. O., Puggal, M. A., Paltoo, D. N., Soldano, K. L., Guasch, A., Ashley‐Koch, A. E., Telen, M. J., et al. (2013) · Blood · doi:10.1182/blood-2013-01-478776 · Cited by 43
The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia
Thein, S. L. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70011-5 · Cited by 45
Self-citationShang, S., Li, X., Azzo, A., Truong, T., Dozmorov, M. G., Lyons, C. E., Manna, A. K., Williams, D. C., & Ginder, G. D. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302254120 · Cited by 47
Whole genome association studies in complex diseases: where do we stand?
Need, A. C., & Goldstein, D. B. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/aneed · Cited by 40
Helias, V., Saison, C., Peyrard, T., Vera, E., Préhu, C., Cartron, J., & Arnaud, L. (2012) · Human Mutation · doi:10.1002/humu.22218 · Cited by 40
Structural insights into the recognition of γ-globin gene promoter by BCL11A
Yang, Y., Xu, Z. Z., He, C. J., Zhang, B., Shi, Y., & Li, F. (2019) · Cell Research · doi:10.1038/s41422-019-0221-0 · Cited by 40
Leibovitch, J. N., Tambe, A., Cimpeanu, E., Poplawska, M., Jafri, F. M., Dutta, D., & Lim, S. H. (2022) · Blood Reviews · doi:10.1016/j.blre.2021.100925 · Cited by 44
Akinsheye, I., Solovieff, N., Ngo, D., Malek, A., Sebastiani, P., Steinberg, M. H., & Chui, D. H. K. (2012) · American Journal of Hematology · doi:10.1002/ajh.22221 · Cited by 40
H b A 2 levels in normal adults are influenced by two distinct genetic mechanisms
Menzel, S., Garner, C. P., Rooks, H., Spector, T. D., & Thein, S. L. (2012) · British Journal of Haematology · doi:10.1111/bjh.12084 · Cited by 40
Self-citationSickle Cell Disease at 100 Years
Orkin, S. H., & Higgs, D. R. (2010) · Science · doi:10.1126/science.1194035 · Cited by 46
Genetic therapies for sickle cell disease
Esrick, E. B., & Bauer, D. E. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.014 · Cited by 41
14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts
Lessard, S., Beaudoin, M., Orkin, S. H., Bauer, D. E., & Lettre, G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy051 · Cited by 38
Gene therapy for sickle cell disease: recent advances, clinical trials and future directions
Ballantine, J., & Tisdale, J. F. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.11.006 · Cited by 42
Modifier genes in Mendelian disorders: the example of hemoglobin disorders
Sankaran, V. G., Lettre, G., Orkin, S. H., & Hirschhorn, J. N. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05821.x · Cited by 40
The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease
Adekile, A. D. (2020) · Medical Principles and Practice · doi:10.1159/000511342 · Cited by 45
Genetic architecture of hemoglobin F control
Menzel, S., & Thein, S. L. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328329d07a · Cited by 37
Self-citationGenetic Modifiers of Sickle Cell Disease
Thein, S. L. (2011) · Hemoglobin · doi:10.3109/03630269.2011.615876 · Cited by 40
Self-citationMolecular Medicine: Found in Translation
Orkin, S. H. (2021) · Med · doi:10.1016/j.medj.2020.12.011 · Cited by 39
Metadata
- Authors
- Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., Best, S., Spector, T. D., Farrall, M., Lathrop, M., & Thein, S. L.
- Affiliations
- King's College London (GB)
- University of California, Irvine (US)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- St Thomas' Hospital (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Thein, Swee Lay
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-09-02
- Volume
- 39
- Issue
- 10
- Pages
- 1197-1199
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2036308544
- Cited by
- 529
- References
- 16
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 22 · 2023: 27 · 2022: 24 · 2021: 34 · 2020: 43 · 2019: 25 · 2018: 33 · 2017: 27 · 2016: 37 · 2015: 27 · 2014: 25 · 2013: 26 · 2012: 20
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- fetal hemoglobin, F cells, quantitative trait loci, BCL11A, zinc finger proteins, sickle cell disease, beta-thalassemia, genome-wide association study
- MeSH terms
- Anemia, Sickle Cell, Carrier Proteins, Chromosome Mapping, Chromosomes, Human, Pair 2, Fetal Hemoglobin, Humans, Nuclear Proteins, Phenotype, Repressor Proteins, Genetic Variation, Genome, Human, Zinc Fingers, beta-Thalassemia, Quantitative Trait Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.